BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 21642835)

  • 1. Pulmonary arterial hypertension: classification and therapy with a focus on prostaglandin analogs.
    Papierniak ES; Lowenthal DT; Mubarak K
    Am J Ther; 2012 Jul; 19(4):300-14. PubMed ID: 21642835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled treprostinil for the treatment of pulmonary arterial hypertension.
    Poms A; Kingman M
    Crit Care Nurse; 2011 Dec; 31(6):e1-10. PubMed ID: 22135338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treprostinil for pulmonary hypertension.
    Vachiéry JL; Naeije R
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):183-91. PubMed ID: 15151467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic evaluation of continuous intravenous epoprostenol.
    Chaumais MC; Jobard M; Huertas A; Vignand-Courtin C; Humbert M; Sitbon O; Rieutord A; Montani D
    Expert Opin Drug Metab Toxicol; 2010 Dec; 6(12):1587-98. PubMed ID: 21077785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostanoid therapy for pulmonary arterial hypertension.
    Strauss WL; Edelman JD
    Clin Chest Med; 2007 Mar; 28(1):127-42; ix. PubMed ID: 17338932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of treprostinil sodium for the treatment of pulmonary arterial hypertension.
    Budev MM; Minai OA; Arroliga AC
    Drugs Today (Barc); 2004 Mar; 40(3):225-34. PubMed ID: 15148531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary hypertension update.
    Hesselgrave B
    Case Manager; 2005; 16(6):61-6; quiz 67. PubMed ID: 16326325
    [No Abstract]   [Full Text] [Related]  

  • 8. Practical considerations for the pharmacotherapy of pulmonary arterial hypertension.
    Bishop BM; Mauro VF; Khouri SJ
    Pharmacotherapy; 2012 Sep; 32(9):838-55. PubMed ID: 22806762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of pulmonary arterial hypertension: the role of prostacyclin and prostaglandin analogs.
    Safdar Z
    Respir Med; 2011 Jun; 105(6):818-27. PubMed ID: 21273054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of prostaglandin analogs in the management of patients with pulmonary arterial hypertension.
    Mubarak KK
    Respir Med; 2010 Jan; 104(1):9-21. PubMed ID: 19683911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous intravenous epoprostenol in pulmonary hypertension: the Israel experience.
    Bendayan D; Fink G; Aravot D; Ygla M; Bendov I; Bliden L; Nir A; Kramer MR
    Isr Med Assoc J; 2002 Apr; 4(4):255-8. PubMed ID: 12001697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treprostinil for the treatment of pulmonary arterial hypertension in patients with New York Heart Association class II-IV symptoms.
    Herald N; Laliberte K
    Pharmacotherapy; 2006 Aug; 26(8):1203; discussion 1203-4. PubMed ID: 16863500
    [No Abstract]   [Full Text] [Related]  

  • 13. [Current approach to the treatment of pulmonary arterial hypertension and our experience in the Cardiology Department of Medicine Faculty of Ege University].
    Kayikçioğlu M; Kültürsay H
    Turk Kardiyol Dern Ars; 2009 Dec; 37(8):580-90. PubMed ID: 20200464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential for inhaled treprostinil in the treatment of pulmonary arterial hypertension.
    Gessler T; Seeger W; Schmehl T
    Ther Adv Respir Dis; 2011 Jun; 5(3):195-206. PubMed ID: 21300738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical therapy for pulmonary arterial hypertension.
    Driscoll JA; Chakinala MM
    Expert Opin Pharmacother; 2008 Jan; 9(1):65-81. PubMed ID: 18076339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bloodstream infections in patients given treatment with intravenous prostanoids.
    Kallen AJ; Lederman E; Balaji A; Trevino I; Petersen EE; Shoulson R; Saiman L; Horn EM; Gomberg-Maitland M; Barst RJ; Srinivasan A
    Infect Control Hosp Epidemiol; 2008 Apr; 29(4):342-9. PubMed ID: 18462147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in prostanoid infusion therapy for pulmonary arterial hypertension.
    Doran A; Harris S; Goetz B
    J Infus Nurs; 2008; 31(6):336-45. PubMed ID: 19018187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.
    McLaughlin VV; Genthner DE; Panella MM; Rich S
    N Engl J Med; 1998 Jan; 338(5):273-7. PubMed ID: 9445406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
    Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
    Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacological treatment of pulmonary arterial hypertension.
    Frumkin LR
    Pharmacol Rev; 2012 Jul; 64(3):583-620. PubMed ID: 22659328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.